VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

MODI’IN, Israel and NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Read more at globenewswire.com